Vanguard Group »

Maplight Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Maplight Therapeutics shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $15M 870k 17.56